A2AR antagonist 1
CAS: 443103-97-7
Ref. 3D-TSA10397
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Informação sobre produto
VIPadenant is a small molecule that has been developed to selectively inhibit the adenosine A2A receptor. It has the ability to modulate immune responses by inhibiting the production of pro-inflammatory cytokines and chemokines in Th17 cells, which are cells that play a role in autoimmune diseases such as multiple sclerosis and rheumatoid arthritis. VIPadenant also inhibits lipase activity and blocks adenosine from binding to its receptors, which may lead to an increased metabolism of fat. The drug has shown an ability to inhibit cancer cell proliferation, and has been patented for use as a potential anti-cancer agent.
Propriedades químicas
Consulta técnica sobre: 3D-TSA10397 A2AR antagonist 1
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
